SIGHINOLFI, GIAN LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.147
AS - Asia 1.185
EU - Europa 889
SA - Sud America 172
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 9
Totale 4.475
Nazione #
US - Stati Uniti d'America 2.072
SG - Singapore 429
CN - Cina 219
IT - Italia 162
GB - Regno Unito 151
FI - Finlandia 145
HK - Hong Kong 144
BR - Brasile 132
VN - Vietnam 121
SE - Svezia 115
DE - Germania 102
BD - Bangladesh 98
RU - Federazione Russa 55
FR - Francia 42
IN - India 38
CA - Canada 36
MX - Messico 27
KR - Corea 26
ID - Indonesia 20
ZA - Sudafrica 19
AR - Argentina 18
PL - Polonia 15
IQ - Iraq 13
BG - Bulgaria 12
UA - Ucraina 11
LT - Lituania 10
MY - Malesia 10
SI - Slovenia 10
AT - Austria 9
JP - Giappone 9
PK - Pakistan 9
UZ - Uzbekistan 9
AU - Australia 8
DK - Danimarca 8
ES - Italia 8
MA - Marocco 8
NL - Olanda 8
TR - Turchia 8
BE - Belgio 7
KE - Kenya 6
CL - Cile 5
CO - Colombia 5
IR - Iran 5
PH - Filippine 5
VE - Venezuela 5
JO - Giordania 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
BY - Bielorussia 3
NI - Nicaragua 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZM - Zambia 1
Totale 4.449
Città #
Ashburn 340
Singapore 295
Santa Clara 235
Chandler 169
Hong Kong 143
Fairfield 141
Helsinki 127
San Jose 112
Nyköping 76
Houston 61
London 61
Woodbridge 53
Council Bluffs 52
Los Angeles 46
Seattle 46
The Dalles 43
Southend 39
Munich 37
New York 37
Wilmington 37
Beijing 36
Cambridge 36
Ho Chi Minh City 32
Hefei 27
Modena 26
Seoul 26
Chicago 25
Hanoi 25
San Diego 22
Dallas 18
Princeton 18
Shanghai 18
Bremen 17
Lauterbourg 17
Turku 17
Ann Arbor 16
Jakarta 16
Johannesburg 16
Milan 16
Fremont 15
Da Nang 14
Jacksonville 14
Brooklyn 12
Sofia 12
São Paulo 12
Atlanta 11
Moscow 11
Orem 11
Portsmouth 11
Warsaw 11
Phoenix 10
Toronto 10
Chennai 9
Dearborn 9
Mexico City 9
Parma 9
Baghdad 8
Buffalo 8
Genoa 8
Montreal 8
Mumbai 8
Frankfurt am Main 7
Nuremberg 7
Ottawa 7
Rome 7
Stockholm 7
Sydney 7
Tokyo 7
Denver 6
Nairobi 6
Poplar 6
Redondo Beach 6
Rio de Janeiro 6
Salt Lake City 6
Tashkent 6
Amsterdam 5
Manchester 5
Amman 4
Birmingham 4
Biên Hòa 4
Boardman 4
Bologna 4
Changsha 4
Dong Ket 4
Düsseldorf 4
Ghent 4
Haiphong 4
Padua 4
Querétaro 4
San Mateo 4
Secaucus 4
Belgrade 3
Belo Horizonte 3
Bexley 3
Brussels 3
Bucharest 3
Cagliari 3
Charlotte 3
City of London 3
Columbus 3
Totale 2.988
Nome #
Carcinogenic potential of metal nanoparticles in BALB/3T3 cell transformation assay. 375
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 358
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 286
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 279
A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living with HIV 275
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 270
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 269
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 269
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 244
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 232
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 230
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 209
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 208
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 192
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 191
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 189
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 165
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection 152
Tossicità in vitro di nanoparticelle metalliche in linee e colture cellulari neuronali 82
Totale 4.475
Categoria #
all - tutte 20.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022237 0 12 9 5 13 12 8 13 42 12 51 60
2022/2023475 69 67 36 41 58 50 14 52 41 0 19 28
2023/2024281 8 16 24 36 53 34 25 32 4 10 15 24
2024/2025917 25 10 13 79 149 139 84 41 129 43 66 139
2025/20262.017 133 74 127 232 336 166 273 83 170 194 139 90
2026/202741 41 0 0 0 0 0 0 0 0 0 0 0
Totale 4.475